We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Breath Test Detects Lung Cancer

By HospiMedica staff writers
Posted on 07 Dec 2006
It is possible to detect DNA methylation in the breath of smokers and lung cancer patients, suggesting that it may be possible to use this technique to identify people who have undiagnosed lung cancer or are at high risk of developing the disease. More...
DNA methylation is a kind of chemical modification of the cell's DNA, a process known to be associated with lung and other cancers.

The assay simultaneously detects the presence of methylation in six tumor-suppressor genes. Methylation is a process by which a gene is chemically silenced. The assay examines the promoter region of a gene where certain cytosine nucleotide bases may be methylated, preventing the gene from being expressed. To test the assay, people were asked to breathe for 10 minutes into a commercially available device, which cooled the air and formed a condensed vapor. Next, an assay was applied that detects chemical changes--specifically, a DNA methylated form of tumor-suppressor genes.

"The breath test was successful in finding cancer markers,” said Dr. Simon D. Spivack, a pulmonologist at the Wadsworth Center, the public health laboratory of the New York State Department of Health (Albany, NY, USA). The assay was presented at the annual meeting of the American Association for Cancer Research, held in Boston (MA, USA) in November 2006.

Doctors have long sought a reliable early detection method for lung cancer. Even when something that looks like a predictor of cancer is found, such as a nodule on the lung during a CT scan, it is still not a foolproof way to determine who will get cancer, Dr. Spivack said. "What we find in middle-age smokers is that 20-80% of these people have nodules,” he said. "But 95% of the nodules are not cancer and are not going to be.”

"The concept of testing exhaled breath is not new--that [is] what breathalyzers do when they measure small volatile molecules such as alcohol, as well as inflammation molecules that are currently being assayed to test the activity of asthma and other lung diseases,” said Dr. Spivack. "But what is rather remarkable here is that DNA can be tested in the air that comes from the lungs and airways, and that it might be possible to use this in diagnosis of lung cancer in particular, and gene-dysregulation disorders of the lung, in general.”



Related Links:
Wadsworth Center

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.